MENU

REPL Replimune Group Forecast, Technical & Fundamental Analysis

Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies... Show more

Industry: #Biotechnology
REPL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
REPL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

REPL is expected to report earnings to rise 4.40% to -75 cents per share on October 29

Replimune Group REPL Stock Earnings Reports
Q3'26
Est.
$-0.75
Q2'26
Missed
by $0.07
Q1'26
Missed
by $0.07
Q4'25
Missed
by $0.01
Q3'25
Missed
by $0.13
The last earnings report on August 14 showed earnings per share of -72 cents, missing the estimate of -64 cents. With 446.23K shares outstanding, the current market capitalization sits at 1.18B.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLF78.040.17
+0.22%
Sun Life Financial
SIM27.49N/A
N/A
Groupo Simec SAB de CV
MLTX10.14-0.27
-2.59%
MoonLake Immunotherapeutics
LOVE14.09-0.49
-3.36%
Lovesac Company (The)
LEDS2.02-0.09
-4.27%
SemiLEDS Corp

REPL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, REPL has been loosely correlated with IMNN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if REPL jumps, then IMNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REPL
1D Price
Change %
REPL100%
-5.95%
IMNN - REPL
57%
Loosely correlated
-2.80%
SNDX - REPL
49%
Loosely correlated
-3.01%
KYMR - REPL
45%
Loosely correlated
+0.14%
NRIX - REPL
43%
Loosely correlated
+6.96%
ZYME - REPL
42%
Loosely correlated
-1.20%
More
A.I. Advisor
published General Information

General Information

a developer of oncolytic immunotherapies

Industry Biotechnology

Industry
Biotechnology
Address
500 Unicorn Park Drive
Phone
+1 781 222-9600
Employees
465
Web
https://www.replimune.com